glp-1 food industry news today Slideshow: friendly innovations on the upswing Food industry adjusts to GLP-1

Two people can weigh the same and look and function very differently

"Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase)." Journal of Affective Disorders, 2024

GLP-1s lead to a decrease in the production of triglycerides and glucose, and an increase in glucose uptake, which ultimately may improve steatohepatitis, decrease fibrosis progression and reduce the risk of MASH complications

According to FDA labeling for semaglutide products, the incidence of gastrointestinal adverse events typically decreases over time with continued treatment at the same dose level

Why This Matters The dose-dependent distinction highlights an important clinical insight: For obesity management, the upper dose range (812 mg) is likely to dominate

Have insulin resistance or prediabetes